“Translational Regenerative Medicine market set to grow to $118bn by 2025” says new Visiongain report

03 February 2020
Pharma

Visiongain has launched a new pharma report Translational Regenerative Medicine Market Forecast 2020-2030: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies.

The high potential earning for companies from products aimed at repairing organs and tissues has led to an increase in the attention given to regenerative medicine research. Developments in stem cell therapies and tissue engineering in particular may catalyse rapid growth in the translational regenerative medicine market over the next decade and beyond.

Ramla Salad, the lead analyst of the report commented "The translational regenerative medicine market is expected to grow significantly due to the advances in technology and improvements in regulatory frameworks. The expected number of gene therapies is anticipated to increase due to the introduction of the Regenerative Medicine Advanced therapy designation (RMAT) because it provides incentives for the development of advanced therapies. In addition, many governments in various regions of the globe have shown an interest in promoting the development of translational regenerative medicine. The strong governmental support has eased the process of product commercialisation and market access which will result in an influx of products reaching the translational regenerative medicine market in the coming decade."

Leading companies featured in the report include Astellas Pharma, Athersys, AxoGen, Inc., Organogenesis Holdings, Inc., Osiris Therapeutics, Inc., uniQure N.V., Vericell Corporation and other companies.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Deep Frozen Packaging Logistics Market Report 2022-2032

The desire for various types of medications to assist combat a growing number of chronic diseases & lifestyle-related ailments is fuelling the overall deep freeze packaging logistics market demand.

14 January 2022

Read

Visiongain Publishes Pre-Filled Syringes Market Report 2022-2032

With COVID-19 pandemic, the prefilled syringes business has witnessed a significant growth. Since the outbreak of the pandemic, global market players involved in the development of the prefilled syringes market across the globe have increased their investment in raw materials and resources owing to the rise in demand for home based healthcare services.

11 January 2022

Read

Visiongain Publishes Single-use Bioprocessing Probes & Sensors Market Report 2022-2032

To promote their organic revenue growth and market presence, the top companies are pursuing different strategic initiatives such as OEM collaborations and new product development with better technological intricacy.

05 January 2022

Read

Visiongain Publishes Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2021-2031

Contract manufacturing outsourcing is gaining attraction owing to growing trend of outsourcing among pharmaceutical businesses.

16 November 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever